Latest Updates

Articles posted in the "Latest Updates" are compiled and published into a bulletin quarterly.

Previously published articles are available within the Noridian Bulletins webpage. Exclusions to this include time-sensitive announcements such as: Noridian and CMS educational Events, Ask-the-Contractor Teleconferences, and claims processing downtime.

The information included in the Latest Updates is also available by subscribing to the Noridian email list. Medicare news, regulations, workshop notices, and other related notifications will be delivered to you each week. Register Now!

Articles Source Posted
Noridian Molecular Diagnostic (MolDX) Updates from Provider Suggestion Sep 17, 2024
Portal, IVR and Customer Service Limited Availability on October 4 - 6, 2024 Sep 16, 2024
Reminder - Noridian's Virtual Educational Symposium September 18-19 Sep 16, 2024
Multi-Jurisdictional CAC Meeting Announcement - Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) - October 17, 2024, 2 - 4 p.m. CT Sep 13, 2024
Multijurisdictional Contractor Advisory Committee (CAC) Superficial Radiation Therapy (SRT) For The Treatment Of Nonmelanoma Skin Cancers (NMSC) - Bibliography Sep 13, 2024
Multijurisdictional Contractor Advisory Committee (CAC) Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) - Agenda Sep 13, 2024
Multijurisdictional Contractor Advisory Committee (CAC) Superficial Radiation Therapy (SRT) For The Treatment Of Nonmelanoma Skin Cancers (NMSC) - Key Questions Sep 13, 2024
Outpatient PT/OT/SLT and CORFs Enrollment Differences Webinar - 10/16/2024 Sep 12, 2024
CSC and CSCC Update CR13206 Sep 12, 2024
October 2024 I/OCE Specifications Version 25.3 CR13752 Sep 12, 2024
Hospital Outpatient Prospective Payment System: October 2024 Update CR13784 Sep 12, 2024
Opioid Treatment Program (OTP) Webinar - 10/16/2024 Sep 12, 2024
Changes to the Laboratory NCD Edit Software: January 2025 Update CR13785 Sep 12, 2024
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (A57124) - R5 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R11 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R7 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R6 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R8 - Effective October 1, 2024 Sep 12, 2024
MLN Connects Newsletter: Sept 12, 2024 Sep 12, 2024
Self-Administered Drug Exclusion List (A53032) - R38 - Effective June 4, 2015 Sep 12, 2024